Ironwood Pharmaceuticals, Inc. to Post Q2 2024 Earnings of $0.26 Per Share, Zacks Research Forecasts (NASDAQ:IRWD)
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Get Rating) – Analysts at Zacks Research cut their Q2 2024 earnings per share estimates for shares of Ironwood Pharmaceuticals in a research note issued on Wednesday, April 5th. Zacks Research analyst E. Bagri now anticipates that the biotechnology company will earn $0.26 per share for the quarter, down from […]